Breaking News Instant updates and real-time market news.

TSLA

Tesla

$312.77

7.02 (2.30%)

05:51
02/12/19
02/12
05:51
02/12/19
05:51

Pentagon to review certification of Elon Musk's SpaceX launch vehicles

The Pentagon said on Monday in a memo that it will evaluate the certification for Elon Musk's SpaceX launch vehicles to determine whether the U.S. Air Force complied with certain guidelines. "Our objective is to determine whether the U.S. Air Force complied with the Launch Services New Entrant Certification Guide when certifying the launch system design for the Evolved Expendable Launch Vehicle-class SpaceX Falcon 9 and Falcon Heavy launch vehicles," U.S. Department Of Defense Deputy Inspector General Michael Roark said in the memo. Reference Link

  • 20

    Feb

  • 21

    Feb

TSLA Tesla
$312.77

7.02 (2.30%)

02/11/19
02/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Canaccord with analyst Jed Dorsheimer saying he thinks electric vehicle, or EV, penetration is underappreciated by Wall Street. 2. Avis Budget (CAR) upgraded to Buy from Sell at Goldman Sachs with analyst David Tamberrino saying trading at 6.2 times estimated 2019 EBITDA versus a historical trough multiple of 5.9 times and long-term average 8.4 times, shares of Avis look attractive for mean reversion. 3. Electronic Arts (EA) upgraded to Buy from Neutral at BofA/Merrill with analyst Justin Post citing the surprise start to Apex Legends' new Battle Royale. 4. Hasbro (HAS) upgraded to Buy from Neutral at Monness Crespi. 5. Lloyds Banking (LYG) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
ADAM
02/11/19
UPGRADE
Target $450
ADAM
Buy
Canaccord upgrades Tesla to Buy with Model 3, governance concerns eased
As previously reported, Canaccord upgraded Tesla to Buy from Hold with analyst Jed Dorsheimer stating that he thinks electric vehicle, or EV, penetration is underappreciated by Wall Street. He believes the last two quarters and recent guidance have removed significant concerns for both production capability and profitability of the Model 3. Also, his prior corporate governance concerns were allayed with the addition of Larry Ellison and Ms. Wilson-Thompson as independent directors, Dorsheimer tells investors. Additionally, he sees Tesla as having "an almost insurmountable lead in autonomous driving," the analyst added in his upgrade note. He raised his price target on Tesla shares to $450 from $330.
02/11/19
ADAM
02/11/19
UPGRADE
ADAM
Buy
Tesla upgraded to Buy from Hold at Canaccord
02/05/19
MSCO
02/05/19
NO CHANGE
Target $283
MSCO
Equal Weight
Morgan Stanley says Tesla managing expectations well, but stock fully valued
Morgan Stanley analyst Adam Jonas said Tesla has "very effectively managed expectations for 1Q19 and the full year," but he also believes the stock remains fully valued. Following the company's recent quarterly report, Jonas cut his 2019 unit volume forecast by 8% to 380,000 vehicles, which drove down his 2019 revenue view to $28B from $30B and led him to lower his price target on Tesla shares to $283 from $291. Jonas, who does not believe investors will assume the company is fully self-sufficient from a funding standpoint without a more sustained period of execution despite its recently strong results, keeps an Equal Weight rating on Tesla shares.

TODAY'S FREE FLY STORIES

DIN

Dine Brands

$99.45

10.93 (12.35%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Recommendations
Dine Brands analyst commentary  »

Dine Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFRX

InflaRx

$31.65

-0.83 (-2.56%)

07:23
02/22/19
02/22
07:23
02/22/19
07:23
Initiation
InflaRx initiated  »

InflaRx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNVGY

Lenovo

$0.00

(0.00%)

07:22
02/22/19
02/22
07:22
02/22/19
07:22
Upgrade
Lenovo rating change  »

Lenovo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GWPH

GW Pharmaceuticals

$143.86

-2.16 (-1.48%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ROKU

Roku

$51.47

-2.16 (-4.03%)

07:21
02/22/19
02/22
07:21
02/22/19
07:21
Downgrade
Roku rating change  »

Roku downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$12.33

-0.32 (-2.53%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Hot Stocks
Navient issues statement regarding Canyon nomination of four directors for board »

Navient issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$32.22

-1.54 (-4.56%)

07:20
02/22/19
02/22
07:20
02/22/19
07:20
Downgrade
Xencor rating change  »

Xencor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

GBT

Global Blood Therapeutics

$50.04

-0.45 (-0.89%)

07:19
02/22/19
02/22
07:19
02/22/19
07:19
Initiation
Global Blood Therapeutics initiated  »

Global Blood Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

FIT

Fitbit

$6.62

-0.03 (-0.45%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Downgrade
Fitbit rating change  »

Fitbit downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

STMP

Stamps.com

, FDX

FedEx

$182.28

0.52 (0.29%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Recommendations
Stamps.com, FedEx, UPS, Amazon.com analyst commentary  »

Stamps.com should return…

STMP

Stamps.com

FDX

FedEx

$182.28

0.52 (0.29%)

UPS

UPS

$111.76

0.68 (0.61%)

AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 18

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ARGX

Argenx

$122.20

-2.84 (-2.27%)

07:18
02/22/19
02/22
07:18
02/22/19
07:18
Initiation
Argenx initiated  »

Argenx initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REGN

Regeneron

$418.66

-3.9 (-0.92%)

07:17
02/22/19
02/22
07:17
02/22/19
07:17
Initiation
Regeneron initiated  »

Regeneron assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

BIIB

Biogen

$320.99

-14.02 (-4.18%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Initiation
Biogen initiated  »

Biogen assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    May

MGLN

Magellan Health

$70.81

-1.6 (-2.21%)

07:15
02/22/19
02/22
07:15
02/22/19
07:15
Hot Stocks
Starboard to nominate full slate for election to Magellan Health board »

Starboard Value, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MO

Altria Group

$50.38

-0.14 (-0.28%)

07:14
02/22/19
02/22
07:14
02/22/19
07:14
Periodicals
Despite flavored vape ban, Juul sees $3.4B in revenue in 2019, Bloomberg says »

Despite the fact that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$127.56

-2.17 (-1.67%)

07:12
02/22/19
02/22
07:12
02/22/19
07:12
Initiation
Alexion initiated  »

Alexion initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

MCRB

Seres Therapeutics

$5.83

-0.07 (-1.19%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 18

    May

TREE

LendingTree

$310.22

-4.78 (-1.52%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 14

    Mar

  • 19

    Mar

ANAB

AnaptysBio

$64.87

-0.12 (-0.18%)

07:11
02/22/19
02/22
07:11
02/22/19
07:11
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$88.80

0.35 (0.40%)

07:10
02/22/19
02/22
07:10
02/22/19
07:10
Hot Stocks
United Airlines names Robert Rivkin as SVP and General Counsel »

United Airlines named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

RUTH

Ruth's Hospitality

$25.01

0.35 (1.42%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Ruth's Hospitality raises quarterly dividend to 13c per share »

Subsequent to the end of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MYGN

Myriad Genetics

$31.73

-0.19 (-0.60%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Myriad Genetics announces Vectra study data published »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

INTU

Intuit

$234.85

-1.06 (-0.45%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FAMI

Farmmi

$3.07

-0.04 (-1.29%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Hot Stocks
Farmmi, Fenghengda Food enter cooperation agreement »

Farmmi announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

$208.83

-4.36 (-2.05%)

07:09
02/22/19
02/22
07:09
02/22/19
07:09
Downgrade
Tyler Technologies rating change  »

Tyler Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.